Krystal Biotech (KRYS) Other Working Capital Changes (2017 - 2026)
Krystal Biotech (KRYS) reported Other Working Capital Changes of $1.4 million for Q1 2026, up 168.73% on a YoY basis from $534000.0 in Q1 2025, and up 396.54% sequentially from $289000.0 in Q4 2025.
Krystal Biotech (KRYS) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Krystal Biotech (KRYS) has 7 years of Other Working Capital Changes data on file, last reported at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 168.73% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (down 18.84% YoY), and the FY2025 full-year result was $684000.0, down 51.8% from the prior year.
- Other Working Capital Changes grew to $1.4 million in Q1 2026, from $289000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.3 million in Q4 2024 to a low of -$2.0 million in Q4 2025.
- A 5-year average of $793411.8 and a median of $212000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes plunged 1225.0% in 2022 and soared 58900.0% in 2024, its largest moves.
- Tracing KRYS's Other Working Capital Changes over 5 years: stood at $258000.0 in 2022, then dropped by 15.89% to $217000.0 in 2023, then soared by 203.23% to $658000.0 in 2024, then sank by 56.08% to $289000.0 in 2025, then soared by 396.54% to $1.4 million in 2026.
- Business Quant data shows KRYS's Other Working Capital Changes at $1.4 million in Q1 2026, $289000.0 in Q4 2025, and -$295000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | -476,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Mar 31, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Sep 30, 2024 | -524,000.00 |
| Sep 30, 2024 | -524,000.00 |